CRO Clinical Trial Execution: What a CRO Does Across Phases, Costs, and Where Sponsors Go Wrong

Developing a new therapy is a monumental effort. On average, it takes 10–15 years and over $1 billion to bring a drug from discovery to market. Along the way, sponsors must navigate strict regulations, ensure patient safety, and manage vast amounts of clinical data. Few organizations can sustain this scale in-house — which is why more than 80% of clinical trials worldwide involve a CRO. 

By partnering with a clinical trial CRO, sponsors gain access to experienced teams, global site networks, and proven strategies that accelerate timelines and improve data quality. 

What Is CRO in Clinical Trials? 

A Contract Research Organization (CRO) provides end-to-end services across the drug development lifecycle. CROs manage activities such as protocol design, site selection, patient recruitment, clinical monitoring, data management, biostatistics, pharmacovigilance, regulatory submissions, and quality assurance. In short, they are the operational backbone that allows sponsors to focus on strategy and innovation while ensuring trials meet FDA, EMA, and ICH-GCP requirements. 

By outsourcing to a CRO clinical trial partner, sponsors can accelerate timelines, reduce costs, and benefit from established site networks and advanced technology platforms such as CTMS, EDC, RTSM, and eCOA/ePRO systems. 

What a CRO Actually Does in a Clinical Trial (Phase by Phase)

A strong clinical trial CRO supports every stage: 

Well-chosen CROs can cut timelines significantly. Industry data shows that trials managed by CROs are completed on average about 15% faster than those run solely by sponsors — a gain that directly accelerates patient access and drives earlier revenue. 

Full-Service CRO vs FSP Model 

When choosing a clinical trial CRO, sponsors typically decide between: 

• Full-Service CRO: one partner manages every aspect of the trial. This model offers speed and seamless integration but may be less flexible in specific functions. 

• FSP (Functional Service Provider): the sponsor retains more control, outsourcing only certain functions (e.g., monitoring, data management). This approach adds flexibility and can optimize budgets. 

• Hybrid models combine both, leveraging CRO expertise where it matters most while maintaining internal capabilities. 

For a deeper dive into these models of collaboration, from Full-Service to FSP and Hybrid, explore our detailed article. 

Key Factors for a Successful CRO Clinical Trial 

Working with the right partner is critical. The most successful CRO clinical trials share these characteristics: 

How to Choose the Right Clinical Trial CRO 

Selecting a CRO is one of the most strategic decisions for a sponsor. Use this quick checklist to see if a CRO is the right fit for your clinical trial:

Partner with Cromos Pharma 

At Cromos Pharma, we believe that every clinical trial is a step closer to transforming patient care. With over 21 years of experience as a full-service CRO, we bring together global reach, therapeutic expertise, and a proven track record of operational excellence. 

Our team supports sponsors at every stage — from protocol design and regulatory submissions to patient recruitment, site management, and long-term follow-up. Backed by an ISO 9001:2015–certified quality system, we ensure compliance, efficiency, and speed without compromising data integrity or patient safety. 

Partner with us to accelerate your clinical trial and deliver innovative therapies to patients who cannot afford to wait.